FoleyR.N., ParfreyP.S., SarnakM.J.Epidemiology of cardiovascular disease in chronic renal disease.J Am Soc Nephrol1998; 9(12 Suppl): S16–23.
2.
StackA.G., BloembergenW.E.A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients.Am J Kidney Dis2001; 38: 992–1000.
3.
HarnettJ.D., FoleyR.N., KentG.M., BarreP.E., MurrayD., ParfreyP.S.Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.Kidney Int1995; 47: 884–90.
4.
MaiselA.S., KrishnaswamyP., NowakR.M., McCordJ., HollanderJ.E., DucP.Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med2002; 347: 161–7.
5.
AppleF.S., MurakamiM.M., PearceL.A., HerzogC.A.Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.Clin Chem2004; 50: 2279–85.
6.
MallamaciF., TripepiG., CutrupiS., MalatinoL.S., ZoccaliC.Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.Kidney Int2005; 67: 2330–7.
7.
NakaoK., OgawaY., SugaS., ImuraH.Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides.J Hypertens1992; 10: 907–12.
8.
JoffyS., RosnerM.H.Natriuretic peptides in ESRD.Am J Kidney Dis2005; 46: 1–10.
9.
ZoccaliC., MallamaciF., BenedettoF.A., TripepiG., ParlongoS., CataliottiA.Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients.J Am Soc Nephrol2001; 12: 1508–15.
10.
NaganumaT., SugimuraK., WadaS., YasumotoR., SugimuraT., MasudaC.The prognostic role of brain natriuretic peptides in hemodialysis patients.Am J Nephrol2002; 22: 437–44.
11.
GotoT., TakaseH., ToriyamaT., SugiuraT., KuritaY., TsuruN.Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis.Nephron2002; 92: 610–15.
12.
TakamiY., HorioT., IwashimaY., TakiuchiS., KamideK., YoshiharaF.Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.Am J Kidney Dis2004; 44: 420–8.
13.
CarrS.J., BavanandanS., FentumB., NgL.Prognostic potential of brain natriuretic peptide (bnp) in predialysis chronic kidney disease patients.Clin Sci (Lond)2005; 109: 75–82.
14.
JernbergT., LindahlB., SiegbahnA., AndrenB., FrostfeldtG., LagerqvistB.N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.J Am Coll Cardiol2003; 42: 1909–16.
